Zhongnan Medical Journal Press

Home Results

A total of 39 result was found. Results that relate to Breast

Association of p53 codon 72 polymorphism and breast cancer risk in Chinese women: a systematic review and Meta-analysis

Published on New Medicine 2022,32(1):23-32.
10841 times 3610 times

Wen-Bin XU Cheng-Bing GONG Yao LI Guang-Xin ZHONG Xiang SHEN Bin XU Wen-Long JIANG Jiang-Bo LIU

p53 Gene polymorphism Breast cancer Cancer risk Meta-analysis
Details
LncRNA GATA3-AS1 promotes the proliferation and migration of breast cancer cells and the mechanisms underlying its action

Published on New Medicine 2022,32(1):127-137.
12130 times 5777 times

Qi JIANG Yi-Qing XI Lei WEI

LncRNA GATA3-AS1 Breast cancer Proliferation Migration Regulatory mechanism
Details
A case report of immunotherapy-related breast reactive capillary endothelial proliferation

Published on New Medicine 2023,33(1):74-77.
8493 times 2142 times

Chen JIE Jing YU Ru-Meng LI Jun GONG Cong-Hua XIE

Reactive capillary endothelial proliferation Breast Immunotherapy Camrelizumab
Details
Establishment and validation of a clinical prediction model for medullary carcinoma of breast based on the Surveillance, Epidemiology, and End Results database

Published on New Medicine 2023,33(3):163-172.
11530 times 3278 times

Rong FU Yan-Ru SHI Yue-Xian FU Jun LYU

Medullary carcinoma of breast Nomogram Prognosis SEER
Details
Progress in research into exosomes in breast cancer microenvironment

Published on New Medicine 2021,31(1):197-203.
15065 times 3216 times

Kang-Di LI Wen-Hua LI

Breast cancer Tumor microenvironment Exosomes
Details
Differentially expressed miRNAs in Luminal and Basal-like breast cancer

Published on New Medicine 2021,31(1):178-185.
15558 times 4678 times

Ming-Juan ZHAO Jiang-Bo LIU Qian-Qian YUAN Tong DENG Qiao HUANG Gao-Song WU Cheng FANG

miRNAs Luminal breast cancer Basal-like breast cancer Survival analysis
Details
Progress of phosphorylated proteomics in breast cancer

Published on New Medicine 2020,30(1):449-456.
15366 times 4032 times

Yu-Jiao DENG Na LI Wen-Ge ZHU Zhi-Jun DAI

Phosphorylated proteomics Breast cancer Carcinogenesis Treatment Prognosis
Details
Correlation analysis of preparatory grief and coping styles in patients with breast cancer

Published on Journal of Mathematical Medicine 2023,36(1):61-67.
6330 times 1796 times

Gui-Hua HE Jun-Xia WANG Li-Jiao SHAO

Breast cancer Preparatory grief Coping style
Details
Investigation on the cognition of breastfeeding decision of parturients taking medicines during lactation under the guidance of doctors, pharmacy staff and nusring staff

Published on Chinese Journal of Pharmacoepidemiology 2023,32(2):188-197.
5941 times 1625 times

Si-Ming LIU Xiao-Rui LI Chuan-Chuan DING Ting-Ting WANG

Lactation Breastfeeding Medication Cognitive behavior Questionnaire
Details
Pathological features of HER-2 hypoexpression breast cancer and its effect on neoad-juvant chemotherapy

Published on Journal of Mathematical Medicine 2023,36(4):282-287.
8254 times 1707 times

Jing WANG Nan WANG Xian-Hua QIU

Breast cancer HER-2 Clinicopathological features Neoadjuvant chemotherapy
Details
Survival outcomes after breast-conserving therapy compared with mastectomy for T1-2N0M0 breast cancer patients based on SEER database

Published on New Medicine 2023,33(4):243-251.
11075 times 2179 times

Ya-Jing HUANG Wei-Feng SHI

Breast cancer Breast-conserving therapy Mastectomy SEER database
Details
Cost-effectiveness analysis of abemaciclib plus fulvestrant in the second-line treatment for HR﹢/HER2﹣ advanced breast cancer

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1259-1266.
6895 times 1894 times

Xi ZHAO Xi YAN Ning LI Chun-Xia HOU

Abemaciclib Fulvestrant Hormone receptor-positive breast cancer Markov model Cost-effectiveness analysis
Details
Study on the curcumin-loaded mesoporous silica nanoparticles modified by polydopamine

Published on Frontiers in Pharmaceutical Sciences 2024,27(4):580-587.
10310 times 2156 times

WANG Xiaoning REN Peipei ZHAO Yangguang ZHANG Zhanrui YAN Mengru

Mesoporous silica Polydopamine Curcumin Triple negative breast cancer pH responsive
Details
Efficacy and safety of trastuzumab deruxtecan in the treatment of breast cancer: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(5):539-548.
8914 times 2068 times

ZHANG Xiaoqing LIU Shuai ZHANG Kai LUAN Wei

Trastuzumab deruxtecan Antibody drug conjugates Breast cancer Efficacy Safety Meta-analysis Randomized controlled trial
Details
Progress of clinical research on immunotherapy and antibody-drug conjugates for the treatment of triple-negative breast cancer

Published on Frontiers in Pharmaceutical Sciences 2024,27(5):901-908.
9598 times 1520 times

YANG Dan WANG Jinxiu MAO Dahua

Triple-negative breast cancer Immunotherapy Antibody-drug conjugates Clinical trials Immune checkpoint inhibitors Chemotherapy
Details